Dow Down0.18% Nasdaq Up0.39%

Protalix BioTherapeutics, Inc. (PLX)

-NYSE MKT
2.58 Down 0.02(0.77%) 4:00PM EDT
HeadlinesGet Headlines for:
[audio] [audio] Protalix Biotherapeutics Inc Corporate Call to Discuss ELELYSO Pediatric Approval and Provide Updates on Additional Programs (live tomorrow at 8:30 am ET)

No headlines available for PLX prior to September 19, 2012.